Publications, Pharmaceutical

In Vitro and In Vivo Assessment of Regional Nasal Deposition using Scintigraphy from a Nasal Spray and a Nasal Powder

There is growing recognition that targeted nasal deposition can help to realize the full potential of the nasal route for systemic and nose-to-brain drug delivery. This article describes an experimental study in which gamma scintigraphy was used to compare regional nasal deposition behavior for a nasal spray and nasal powder, with in vitro and in vivo studies. In vitro studies were carried out with a validated nasal cast (use courtesy of Aptar Pharma/DTF/Univ. of Tours). In vivo data was gathered from six healthy volunteers. Both sets of results indicate higher deposition in the olfactory region with the nasal powder. Agreement between in vitro and in vivo results highlights the potential to accelerate nasal drug development studies using appropriate in vitro test methods and nasal casts.

Download Publication
1 Sep 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About nasal drug delivery expertise

This Might Also Be of Interest

2 Nov 2021

Successfully Balancing The Needs of The Planet With The Needs of The Patient

Publications, Pharmaceutical, Sustainability, Innovation & Insights, Device Innovations, Product Solutions

Read More
26 Oct 2021

Using digital healthcare to improve patient compliance and adherence

Webinars, Pharmaceutical, Brand Differentiation, Product Solutions, Innovation & Insights, Device Innovations

Read More
16 Sep 2021

Introducing PureHale® for targeted upper respiratory tract care

Webinars, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
9 Sep 2021

Aptar Pharma talks targeted drug delivery to the upper airways

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions

Read More
1 14 15 16 17 18 25
Back To Top